Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Invest Dermatol ; 133(11): 2555-2565, 2013 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-23633022

RESUMO

It has been recognized that ceramides are decreased in the epidermis of patients with psoriasis and atopic dermatitis. Here, we generated Sptlc2 (serine palmitoyltransferase long-chain base subunit 2)-targeted mice (SPT-cKO mice), thereby knocking out serine palmitoyltransferase (SPT), the critical enzyme for ceramide biosynthesis, in keratinocytes. SPT-cKO mice showed decreased ceramide levels in the epidermis, which impaired water-holding capacity and barrier function. From 2 weeks of age, they developed skin lesions with histological aberrations including hyperkeratosis, acanthosis, loss of the granular layer, and inflammatory cell infiltrates. Epidermal Langerhans cells showed persistent activation and enhanced migration to lymph nodes. Skin lesions showed upregulation of psoriasis-associated genes, such as IL-17A, IL-17F, IL-22, S100A8, S100A9, and ß-defensins. In the skin lesions and draining lymph nodes, there were increased numbers of γδ T cells that produced IL-17 (γδ-17 cells), most of which also produced IL-22, as do Th17 cells. Furthermore, IL-23-producing CD11c(+) cells were observed in the lesions. In vivo treatment of SPT-cKO mice with an anti-IL-12/23p40 antibody ameliorated the skin lesions and reduced the numbers of γδ-17 cells. Therefore, we conclude that a ceramide deficiency in the epidermis leads to psoriasis-like lesions in mice, probably mediated by IL-23-dependent IL-22-producing γδ-17 cells.


Assuntos
Ceramidas/deficiência , Dermatite/metabolismo , Epiderme/metabolismo , Psoríase/metabolismo , Serina C-Palmitoiltransferase/genética , Animais , Dermatite/imunologia , Dermatite/patologia , Modelos Animais de Doenças , Epiderme/patologia , Feminino , Humanos , Interleucina-17/metabolismo , Interleucina-23/genética , Interleucina-23/metabolismo , Interleucinas/genética , Interleucinas/metabolismo , Queratinócitos/metabolismo , Queratinócitos/patologia , Células de Langerhans/imunologia , Células de Langerhans/metabolismo , Células de Langerhans/patologia , Masculino , Camundongos , Camundongos Knockout , Psoríase/imunologia , Psoríase/patologia , Serina C-Palmitoiltransferase/metabolismo , Linfócitos T/imunologia , Linfócitos T/metabolismo , Linfócitos T/patologia , Água/metabolismo , Interleucina 22
2.
J Control Release ; 131(2): 113-20, 2008 Oct 21.
Artigo em Inglês | MEDLINE | ID: mdl-18700159

RESUMO

One of the most important anthropic missions is preventing the global spread of infectious diseases. Vaccination is the only available preventive treatment for infectious diseases, but the availability of vaccines in developing countries is not adequate. We report a simple, easy-to-use, noninvasive hydrogel patch transcutaneous vaccination system. Antigen (Ag)-specific IgG production was induced by applying an Ag-immersed patch to non-pretreated mouse auricle or hairless rat back skin. Immunofluorescence histochemical analysis revealed that Langerhans cells resident in the epidermal layer captured the antigenic proteins delivered by the hydrogel patch, which promoted the penetration of antigenic proteins through the stratum corneum, and that Ag-capturing Langerhans cells migrated into draining lymph nodes. Humoral immunity elicited by our transcutaneous vaccination system demonstrated neutralizing activity in both adenoviral infection and passive-challenge tetanus toxin experiments. The use of this hydrogel patch transcutaneous vaccination system will facilitate the global distribution of effective and convenient vaccines.


Assuntos
Infecções Bacterianas/prevenção & controle , Portadores de Fármacos/administração & dosagem , Hidrogel de Polietilenoglicol-Dimetacrilato/administração & dosagem , Vacinação/métodos , Vacinas/administração & dosagem , Viroses/prevenção & controle , Administração Cutânea , Animais , Formação de Anticorpos/imunologia , Antígenos Virais/administração & dosagem , Infecções Bacterianas/imunologia , Proteínas do Capsídeo/administração & dosagem , Proteínas do Capsídeo/farmacocinética , Linhagem Celular , Sistemas de Liberação de Medicamentos , Feminino , Humanos , Imunoglobulina G/imunologia , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos ICR , Ratos , Ratos Pelados , Absorção Cutânea , Toxoide Tetânico/administração & dosagem , Toxoide Tetânico/farmacocinética , Vacinas/farmacocinética , Viroses/imunologia
3.
Hum Mutat ; 29(2): 331, 2008 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-18205205

RESUMO

Fabry disease is an X-linked recessive inborn metabolic disorder caused by a deficiency of the lysosomal enzyme alpha-galactosidase A (EC 3.2.1.22). The causative mutations are diverse, include both large rearrangements and single-base substitutions, and are dispersed throughout the 7 exons of the alpha-galactosidase A gene (GLA). Mutation hotspots for Fabry disease do not exist. We examined 62 Fabry patients in Japan and found 24 GLA mutations, including 11 novel ones. A potential treatment reported for Fabry disease is active site specific chaperone (ASSC) therapy using 1-deoxygalactonojirimycin (DGJ), an inhibitor of alpha-galactosidase A, at subinhibitory concentrations. We transfected COS-7 cells with the 24 mutant GLAs and analyzed the alpha-galactosidase A activities. We then treated the transfected COS-7 cells with DGJ and analyzed its effect on the mutant enzyme activities. The activity of 11 missense mutants increased significantly with DGJ. Although ASSC therapy is useful only for misfolding mutants and therefore not applicable to all cases, it may be useful for treating many Japanese patients with Fabry disease.


Assuntos
Povo Asiático/genética , Doença de Fabry/enzimologia , Doença de Fabry/genética , Chaperonas Moleculares/metabolismo , Mutação/genética , alfa-Galactosidase/genética , Adolescente , Adulto , Animais , Sítios de Ligação , Células COS , Criança , Chlorocebus aethiops , Humanos , Japão , Pessoa de Meia-Idade
4.
J Invest Dermatol ; 126(6): 1281-5, 2006 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-16439973

RESUMO

The gene encoding human desmoglein 4 (DSG4) was recently cloned, and a mutation in this gene has been reported in several consanguineous Pakistani families affected with localized autosomal recessive hypotrichosis (LAH). In addition, various mutations in the Dsg4 gene have been identified in animal models of hypotrichosis that share a characteristic phenotype called "lanceolate hair". To date, the features of the hair-shaft anomaly in patients with LAH have not been well described. We report a Japanese patient affected with congenital hypotrichosis that was originally diagnosed as monilethrix because she had a hair-shaft abnormality that resembled moniliform hair. However, no mutations were found in the type II hair keratin genes, hHb1, hHb3, and hHb6, whose mutations cause monilethrix. Instead, we identified novel compound heterozygous mutations in the DSG4 gene of our patient. On the maternal allele is a novel S192P transition within the extracellular cadherin II domain of DSG4; on the paternal allele is a novel 2039insT mutation leading to the generation of unstable transcripts. Here we present the observation that mutations in the DSG4 gene can cause monilethrix-like congenital hypotrichosis. Based on our findings, we propose that LAH and monilethrix could overlap.


Assuntos
Desmogleínas/genética , Doenças do Cabelo/genética , Cabelo/ultraestrutura , Hipotricose/genética , Alelos , Sequência de Aminoácidos , Pré-Escolar , Análise Mutacional de DNA , Feminino , Doenças do Cabelo/patologia , Heterozigoto , Humanos , Hipotricose/patologia , Queratinas/genética , Microscopia Eletrônica de Varredura , Dados de Sequência Molecular , Mutação , Estabilidade de RNA , Transcrição Gênica
5.
J Dermatol Sci ; 39(2): 89-96, 2005 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-16055004

RESUMO

BACKGROUND: Previous studies indicate that FXIIIa+ proliferative cells are the cells constituting DFs, however, in spite of the high incidence of DFs, there is a little information in the literature regarding ultrastructural characteristics of the FXIIIa+ dendritic cells on DFs. OBJECTIVES: In this study, we examined the fine structures and potential heterogeneity among the subgroup of factor XIIIa (FXIIIa) positive dendritic cells consisted of eleven cases of dermatofibroma (DF). METHODS: Immunohistochemical, electron microscopical, and immunoelectron microscopical techniques were utilized. RESULTS: We demonstrated (i) the immunohistochemical labeling of FXIIIa and CD68 in the DFs. The reactivity was stronger in histiocytic lesions than in fibroblastic lesions. On the other hand, the labeling of HHF35 was mainly in fibroblastic lesions. (ii) The fibroblastic and histiocytic cells on DFs displayed the same basic fine structures; moderate or abundant rough endoplasmic reticulum (RER), lipid droplets and/or bundles of myofilaments in varying proportions. Macular adherence connections between neighboring cells were common. (iii) They also showed the similar features to dermal dendritic cells (DDC), which have been well characterized with long cytoplasmic processes, abundant RER, fibronexus-like plaques and pinocytotic vesicles. (iv) FXIIIa expressions were found within the cytoplasm of both fibroblastic and histiocytic cells in association with the nucleus by immunoelectron microscopy. The labeling was stronger in the histiocytic cells and the cells expressing elongated cytoplasmic processes than in the fibroblastic cells. CONCLUSION: The FXIIIa+ dendritic cells might be an essential cell of DF, and might have potential to develop HHF35+ fibroblastic or CD68+ histiocytic cells, under appropriate stimuli. The FXIIIa+ dendritic cells might be originated from DDC.


Assuntos
Células Dendríticas/metabolismo , Fator XIIIa/biossíntese , Histiocitoma Fibroso Benigno/patologia , Neoplasias Cutâneas/patologia , Antígenos CD/biossíntese , Antígenos CD/metabolismo , Antígenos de Diferenciação Mielomonocítica/biossíntese , Antígenos de Diferenciação Mielomonocítica/metabolismo , Núcleo Celular/metabolismo , Citoplasma/metabolismo , Células Dendríticas/citologia , Retículo Endoplasmático/metabolismo , Fibroblastos/metabolismo , Histiocitoma Fibroso Benigno/metabolismo , Humanos , Imuno-Histoquímica , Lisossomos/metabolismo , Microscopia Eletrônica , Microscopia Eletrônica de Transmissão , Microscopia Imunoeletrônica , Neoplasias Cutâneas/metabolismo
6.
J Dermatol ; 29(4): 197-201, 2002 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-12027083

RESUMO

Acquired structural hair defects are caused by various physical and chemical manipulations. Plucked hairs and hair follicle biopsy specimens of pili torti-like hairs that arose from pseudopelade scalp were studied. In scanning electron microscopy, the hair shafts had a segmental pili torti-like appearance, accompanied by oblique or longitudinal grooves and ridges. In light microscopy, the hair follicles showed an asymmetric hair bulb and inner root sheath, and a shortened keratogenous zone within sclerosing fibrous connective tissue. In transmission electron microscopy, the numbers and thickness of the hair cuticle cells were different on the opposite sides of the hair shaft. The hair cuticle was irregularly shaped and formed asymmetric waves. The tonofilaments in the hair cortex ran almost parallel to the hair axis. From these findings, it was clear that the grooves and ridges were produced by the deformed hair cuticle and cortex, whose shapes were modulated by the asymmetric inner root sheath. This asymmetry most likely resulted from a dysfunctional dermal papilla, which was affected by fibrosis. The pili torti-like appearance appeared to be caused by the grooves and ridges that ran obliquely on the hair shaft surface.


Assuntos
Alopecia/patologia , Cabelo/ultraestrutura , Adolescente , Alopecia/etiologia , Cabelo/anormalidades , Folículo Piloso/ultraestrutura , Humanos , Masculino
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA